Cerapedics announces FDA approval of PMA supplement based on two-year clinical data

Cerapedics announces FDA approval of PMA supplement based on two-year clinical data

WESTMINSTER -- Cerapedics, a private ortho-biologics company, announced the U.S. Food and Drug Administration (FDA) has approved the company's Premarket Approval (PMA) supplement for i-FACTOR... Read More

Tuesday November 19, 2019 0 comments Tags: Westminster, Cerapedics, Jeffrey Marx, Glen Kashuba

Cerapedics appoints Patrick O’Connor VP of clinical and market development

Cerapedics appoints Patrick O’Connor VP of clinical and market development

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, today announced the appointment of Patrick O'Connor as VP of Clinical and Market Development. "We are pleased to welcome... Read More

Tuesday June 25, 2019 0 comments Tags: Westminster, Cerapedics, Patrick O'Connor, Jeffrey Marx

INterview with Jeffrey Marx, Cerapedics president and COO

INterview with Jeffrey Marx, Cerapedics president and COO

Jeffrey (Jeff) G. Marx , Ph.D. is a senior executive with over 20 years of experience in the medical device space. His experience includes successful leadership roles spanning RD, business... Read More

Monday November 6, 2017 0 comments Tags: Denver, Jeffrey Marx, Cerapedics